Frequent IBD Meds Acquitted in Severe COVID Outcomes

Frequent IBD Meds Acquitted in Severe COVID Outcomes

Each and every biologics and mesalamine/sulfasalazine were no longer linked to extreme COVID-19 outcomes in inflammatory bowel illness (IBD) sufferers, in step with findings from the ongoing global SECURE-IBD trial. There became once no affiliation between mesalamine/sulfasalazine and negative COVID…